NCT06354114View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2026

Conditions
Advanced Breast Cancer
Interventions
DRUG

SYHX2011

IV infusion, 260 mg/m\^2

Trial Locations (1)

Unknown

Harbin Medical University Cancer Hospital, Harbin

Sponsors
All Listed Sponsors
lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06354114 - A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011 | Biotech Hunter | Biotech Hunter